Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-01 Option Award |
2022-08-19 5:38 pm |
N/A 2032-06-01 |
Rain Therapeutics Inc. | RAIN | Wolff Stefani Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-01 Option Award |
2022-08-19 5:35 pm |
N/A 2032-06-01 |
Rain Therapeutics Inc. | RAIN | Radovich Peter Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-01 Option Award |
2022-08-19 5:34 pm |
N/A 2032-06-01 |
Rain Therapeutics Inc. | RAIN | Hrustanovic Gorjan Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-07-06 Exercise |
2022-07-07 6:02 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks |
3,890 | $3.95 | 481,827 (Direct) |
View |
| 2022-07-06 Exercise |
2022-07-07 6:02 pm |
N/A 2029-03-13 |
Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks |
3,890 | $0 | 481,827 (Direct) |
View |
| 2022-04-14 Gift |
2022-04-15 4:30 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | Vellanki Avanish Chairman and CEO 10% Owner |
59,618 | $0 | 2,525,910 (Indirect) |
View |
| 2022-04-13 Exercise |
2022-04-15 4:30 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks |
3,000 | $3.95 | 481,827 (Direct) |
View |
| 2022-04-13 Exercise |
2022-04-15 4:30 pm |
N/A 2029-03-13 |
Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks |
3,000 | $0 | 481,827 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-04 4:15 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks |
2,000 | $3.95 | 481,827 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-04 4:15 pm |
N/A 2029-03-13 |
Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks |
2,000 | $0 | 481,827 (Direct) |
View |
| 2022-03-11 Exercise |
2022-03-15 3:23 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | Vellanki Avanish President and CEO |
14,468 | $4 | 3,007,742 (Direct) |
View |
| 2022-03-11 Exercise |
2022-03-15 3:23 pm |
N/A 2030-11-12 |
Rain Therapeutics Inc. | RAIN | Vellanki Avanish President and CEO |
14,468 | $0 | 3,007,742 (Direct) |
View |
| 2022-01-07 Option Award |
2022-02-04 4:45 pm |
N/A 2032-01-07 |
Rain Therapeutics Inc. | RAIN | Cabatuan Nelson See Remarks |
32,000 | $0 | 32,000 (Direct) |
View |
| 2022-01-07 Option Award |
2022-02-04 4:40 pm |
N/A 2032-01-07 |
Rain Therapeutics Inc. | RAIN | BRYCE RICHARD PAUL Chief Medical Officer |
53,064 | $0 | 53,064 (Direct) |
View |
| 2022-01-07 Option Award |
2022-02-04 4:35 pm |
N/A 2032-01-07 |
Rain Therapeutics Inc. | RAIN | Doebele Robert EVP, Chief Scientific Officer |
72,000 | $0 | 72,000 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-04 4:30 pm |
N/A 2032-02-02 |
Rain Therapeutics Inc. | RAIN | Vellanki Avanish President and CEO |
182,300 | $0 | 182,300 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 5:46 pm |
N/A 2031-05-14 |
Rain Therapeutics Inc. | RAIN | BERGER FRANKLIN M Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 5:44 pm |
N/A 2031-05-14 |
Rain Therapeutics Inc. | RAIN | Wolff Stefani Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2021-05-12 Option Award |
2021-05-14 6:37 pm |
N/A 2031-05-12 |
Rain Therapeutics Inc. | RAIN | Cabatuan Nelson See Remarks |
6,000 | $0 | 6,000 (Direct) |
View |
| 2021-04-27 Conversion |
2021-04-29 4:02 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund II LP Former 10% Owner |
4,839,218 | $0 | 2,776,657 (Indirect) |
View |
| 2021-04-23 Option Award |
2021-04-27 8:41 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks |
98,302 | $15.93 | 1,824,487 (Direct) |
View |
| 2021-04-26 Option Award |
2021-04-27 8:41 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks |
27,413 | $14.9 | 1,824,487 (Direct) |
View |
| 2021-04-23 Conversion |
2021-04-27 8:41 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks |
3,795,295 | $0 | 1,824,487 (Direct) |
View |
| 2021-04-23 Option Award |
2021-04-27 8:41 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks |
1,007,594 | $17 | 1,824,487 (Direct) |
View |
Ownership |
2021-04-27 8:38 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks |
0 | $0 | 3,795,295 (Direct) |
View |
| 2021-04-27 Conversion |
2021-04-27 7:30 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
4,132,803 | $0 | 2,537,019 (Indirect) |
View |
| 2021-04-27 Conversion |
2021-04-27 5:11 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH Director 10% Owner |
6,286,475 | $0 | 4,277,215 (Direct) |
View |
| 2021-04-27 Conversion |
2021-04-27 5:09 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | Davis Aaron I. MVA Investors LLC Director 10% Owner |
6,452,298 | $0 | 4,277,215 (Indirect) |
View |
| 2021-04-27 Conversion |
2021-04-27 5:07 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | Radovich Peter Director |
18,296 | $0 | 8,796 (Indirect) |
View |
| 2021-04-27 Conversion |
2021-04-27 5:05 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | BERGER FRANKLIN M Director |
1,479,935 | $0 | 836,540 (Direct) |
View |
| 2021-04-27 Conversion |
2021-04-27 5:04 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | Doebele Robert EVP, Chief Scientific Officer |
10,259 | $0 | 467,937 (Direct) |
View |
| 2021-04-27 Conversion |
2021-04-27 5:01 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | Vellanki Avanish President and CEO |
23,320 | $0 | 2,511,442 (Direct) |
View |
Ownership |
2021-04-22 7:37 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
0 | $0 | 1,987,019 (Indirect) |
View |
Ownership |
2021-04-22 7:27 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH Director 10% Owner |
0 | $0 | 3,263,986 (Direct) |
View |
Ownership |
2021-04-22 7:24 pm |
N/A N/A |
Rain Therapeutics Inc. | RAIN | Davis Aaron I. MVA Investors LLC Director 10% Owner |
0 | $0 | 3,350,083 (Indirect) |
View |